Skip to content

What's New — Foot — September 2026

10 new articles published this month.

Themes: Talar osteochondral lesion management · Minimally invasive and technical innovations · Hallux and forefoot surgery · Infection and osteomyelitis · Ligamentous instability and tendon considerations

Digest generated 2026-10-04 16:27:53+00:00.


Highlights

Talar osteochondral lesion management

Two articles address osteochondral lesions of the talus. Xu et al. report ≥10-year outcomes after bone marrow stimulation, showing that age >45, longer preoperative symptom duration, and deeper bone marrow edema negatively impact long-term clinical and radiological results [5]. Chen et al. describe two novel assistive devices, a sizing template and an impactor rod, for autologous osteochondral transplantation in large talar lesions, demonstrating improved surgical accuracy and good mid-term outcomes in 34 patients [10]. Together, these studies refine both first-line arthroscopic treatment and advanced cartilage restoration strategies for this challenging pathology.

Minimally invasive and technical innovations

This theme covers novel or refined surgical techniques across the foot and ankle. Pan et al. describe endoscopic resection of a sinus tarsi ganglion extending to the anterolateral ankle, combining ganglionectomy and sinus tarsi debridement through one portal set for faster recovery and lower recurrence [1]. Keith et al. quantify cartilage disruption from retrograde intramedullary screw fixation of metatarsal fractures in a cadaveric model, showing progressively greater articular damage from the 2nd to 5th metatarsals [8]. Testa et al. evaluate the calcaneo-stop arthroereisis with FIT-CS for juvenile flexible flatfoot, reporting favorable medium-term clinical and radiographic outcomes [6].

Hallux and forefoot surgery

Two studies focus on the first ray. Wang et al. use a cadaveric model to demonstrate that the plantar fascia, flexor hallucis longus, and the fibro-osseous tunnel contribute to functional hallux rigidus by limiting first MTP dorsiflexion during weight bearing [3]. Partio et al. present a pilot randomized controlled trial comparing bioabsorbable versus titanium screw fixation in first MTP joint arthrodesis, finding equivalent functional improvement, union rates, and complications at 2 years [7]. These papers advance both the biomechanical understanding and fixation options in hallux surgery.

Infection and osteomyelitis

Kundakci et al. retrospectively compare 202 surgically treated osteomyelitis patients, contrasting foot versus non-foot locations. Foot osteomyelitis was more often linked to diabetic foot infections and contiguous spread, whereas non-foot cases more frequently arose from post-traumatic, hematogenous, or postoperative sources, with distinct microbiological profiles. These findings underscore the need for location-specific diagnostic and treatment pathways in osteomyelitis management.

Ligamentous instability and tendon considerations

Fleury et al. offer an expert opinion reframing the deltoid ligament as a tri-articular stabilizer of the tibio-talar, subtalar, and talo-navicular joints, warning that neglecting its broader role can lead to post-traumatic plano-valgus deformities [9]. Okutan et al. review the peroneus longus tendon as an ACL reconstruction autograft, addressing concerns about donor-site foot biomechanics and summarizing evidence supporting comparable outcomes to established grafts with generally favorable donor-site function [4]. Both papers highlight the foot's role in broader lower-limb stability and graft harvesting decisions.

Articles by Theme

Talar osteochondral lesion management (2)

5. Xu L, Cheng X, Li J, et al. Age Greater Than 45, Preop Symptom Duration, and Bone Marrow Edema Depth Negatively Impact Long‐Term Outcomes After Bone Marrow Stimulation for Osteochondral Lesions of the Talus. Arthroscopy 2026. doi:10.1002/arj.70562

In 103 patients with small osteochondral lesions of the talus (<150 mm²) treated with bone marrow stimulation and followed at least 10 years (mean 11.8), all age groups improved significantly in pain, function, quality of life, and MOCART-assessed cartilage repair. Patients younger than 30 achieved the best outcomes, while age >45, longer preoperative symptom duration, and greater bone marrow oedema depth negatively affected long-term results. These findings support early BMS treatment and suggest older patients with adverse prognostic factors may warrant alternative or adjunctive cartilage repair strategies.

10. Chen Y, Li M, Fang Z, et al. Design and Application of Two Novel Assistive Devices in Autologous Osteochondral Transplantation for Talar Osteochondral Lesions: A Technical Note. Orthopaedics & Traumatology: Surgery & Research 2026. doi:10.1016/j.otsr.2026.104875

The authors designed two assistive devices, a sizing template for graft orientation and an impactor rod for graft insertion, to improve autologous osteochondral transplantation for large talar osteochondral lesions, and evaluated them in a retrospective series of 34 patients. At a mean follow-up of 69 months, pain and function scores improved significantly with good MRI-based MOCART scores. These devices may facilitate surgical accuracy and support favourable clinical outcomes in AOT for talar osteochondral lesions.

Minimally invasive and technical innovations (3)

1. Pan X, Lui TH, Hong J, et al. Endoscopic Resection of Sinus Tarsi Ganglion Extended to the Anterolateral Ankle. Arthroscopy Techniques 2026. doi:10.1002/atn2.70307

The authors describe a minimally invasive endoscopic technique for resecting a sinus tarsi ganglion that extends into the anterolateral ankle, combining ganglionectomy with sinus tarsi debridement through the same set of portals. The technical note details portal placement and operative steps for this approach. By avoiding open excision, the technique is proposed to offer faster recovery and reduced recurrence for symptomatic ganglia refractory to conservative treatment.

6. Testa G, Sapienza M, Marchetti M, et al. Evaluation of the calcaneo-stop procedure with FIT-CS for the surgical treatment of juvenile flatfoot. International Orthopaedics 2026. doi:10.1007/s00264-026-07030-8

This retrospective study of prospectively collected data evaluated 121 children (218 feet) undergoing Calcaneo-stop arthroereisis with FIT-CS for symptomatic flexible flatfoot, with 3-year follow-up using AOFAS, OxAFQ-C, and Catania scores plus radiographic angles. Clinical and functional scores improved markedly (e.g., AOFAS from ~45 to ~92), with corresponding radiographic correction of Kite's and Costa-Bertani angles. The calcaneo-stop procedure appears to provide durable medium-term correction and functional improvement in juvenile flexible flatfoot.

8. Keith B, Burke J, Hynes K, et al. Cartilage disruption patterns associated with percutaneous intramedullary screw fixation for metatarsal fractures: a cadaveric study. Archives of Orthopaedic and Trauma Surgery 2026. doi:10.1007/s00402-026-06457-3

In 14 fresh-frozen cadaveric feet (56 lesser metatarsals), standardised retrograde intramedullary screw fixation (3.6 mm) produced mean articular cartilage disruption that increased from the 2nd to 5th metatarsal (10.17%, 17.43%), with screws consistently in the middle third medially-laterally and mostly in the 2nd, 3rd dorsal-to-plantar quadrants. The study quantifies and maps the iatrogenic cartilage injury inherent to this technique. Surgeons should weigh the progressive articular damage, greatest in the 4th and 5th metatarsals, when selecting intramedullary screw fixation for metatarsal fractures.

Hallux and forefoot surgery (2)

3. Wang M, Hunter Aitchison A, Orriols AM, et al. The role of the plantar fascia, flexor hallucis longus, and fibro-osseous tunnel in functional hallux rigidus. Archives of Orthopaedic and Trauma Surgery 2026. doi:10.1007/s00402-026-06489-9

In 14 cadaveric lower limbs, the authors manipulated the plantar fascia (shortened/lengthened), flexor hallucis longus (shortened), and fibro-osseous tunnel (released) and measured first MTP dorsiflexion using the Dananberg technique. Shortening the plantar fascia or FHL did not significantly reduce dorsiflexion beyond the baseline of about 23.8°, while lengthening the plantar fascia increased dorsiflexion by roughly 6.7°. The results question the primacy of plantar fascia and FHL tension in functional hallux rigidus and suggest other structures, such as the fibro-osseous tunnel, may contribute to weight-bearing limitation.

7. Partio N, Mattila V, Waris V, et al. Bioabsorbable vs. titanium screws in first metatarsophalangeal joint arthrodesis: a pilot randomized controlled trial with 2-year follow-up. Archives of Orthopaedic and Trauma Surgery 2026. doi:10.1007/s00402-026-06501-2

In a 30-patient pilot randomised controlled trial, first MTP joint arthrodesis with bioabsorbable cannulated lag screws was compared with titanium screws using a cup-and-cone technique, with follow-up at 3-24 months. Both groups improved substantially with no significant between-group differences in AOFAS or FA-VAS scores; union was 90% overall with three nonunions (one titanium, two bioabsorbable) requiring revision and no implant-related complications. Bioabsorbable fixation appears feasible with comparable preliminary outcomes, warranting larger trials to confirm equivalence.

Infection and osteomyelitis (1)

2. Kundakci B, Dalgic Y, Dalkir KA, et al. Clinical, etiological, and microbiological differences between foot and non-foot osteomyelitis. Archives of Orthopaedic and Trauma Surgery 2026. doi:10.1007/s00402-026-06486-y

This retrospective study compared clinical, etiological, and microbiological features of 202 surgically treated adult osteomyelitis patients, divided into foot (n=89) and non-foot (n=113) groups using only intraoperative deep tissue/bone cultures. Foot osteomyelitis was predominantly linked to diabetic foot infections and contiguous spread, whereas non-foot cases more often arose from post-traumatic, hematogenous, or postoperative sources, with differing microbiological profiles. The findings support tailoring empirical antibiotic therapy and surgical strategy to the anatomic site and underlying etiology of osteomyelitis.

Ligamentous instability and tendon considerations (2)

4. Okutan AE, Budhiparama N, Herbort M, et al. Peroneus longus tendon autograft for anterior cruciate ligament reconstruction: Current evidence, donor‐site complications and patient selection. Knee Surgery, Sports Traumatology, Arthroscopy 2026. doi:10.1002/ksa.70616

This narrative review synthesizes anatomical, biomechanical, and clinical evidence on the peroneus longus tendon as an autograft for ACL reconstruction, including donor-site morbidity and patient selection considerations. Available comparative studies show broadly similar short- to mid-term outcomes to established autografts with generally favourable donor-site function, but the evidence is largely retrospective and heterogeneous, so equivalence or noninferiority is not established. Clinicians may consider PLT grafts, particularly when avoiding additional knee morbidity, but questions remain regarding ankle performance in high-demand athletes and long-term donor-site consequences.

9. Fleury C, Acker A, Dubois-Ferrière V, et al. Deltoid ligament injury: thinking beyond the ankle – an expert opinion. EFORT Open Reviews 2026. doi:10.1530/eor-2025-0268

This expert opinion synthesizes anatomical, biomechanical, and clinical evidence to reframe the deltoid ligament as a tri-articular stabilizer of the tibio-talar, subtalar, and talo-navicular joints rather than an isolated ankle structure. The authors argue that neglecting this broader role can lead to irreversible post-traumatic plano-valgus or plano-abductus deformities. Clinically, deltoid ligament injuries should be systematically assessed in both acute and chronic settings, regardless of whether treatment is conservative or surgical.

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.